Thus, the strategy to knock out Egln1 in mice was reliable and successful, and the deletion of Egln1 exhibits no obvious effects on the expression of Ifn-β or Isg15 in the lung, spleen, and liver without virus infection (Supplementary Fig. 6d–f). This evidence concerns the gene IFNB1 and viral infectious disease.